Serum soluble interleukin-2 receptor in eosinophilia

Acta Haematol. 2003;109(1):23-8. doi: 10.1159/000067274.

Abstract

The relationship between soluble interleukin-2 receptor (sIL-2R) levels and clinical characteristics was evaluated in patients with eosinophilia. Thirty-eight out of 60 patients showed sIL-2R levels of more than 800 U/ml. In these patients, sIL-2R was closely related to the eosinophil count, but not the IgE level. Their underlying diseases were heterogeneous, including neoplasms and collagen diseases. In patients with lower sIL-2R levels, there was no relationship to the eosinophil count, but sIL-2R was correlated with the IgE level. These findings indicate that patients with eosinophilia and higher sIL-2R levels tend to have underlying diseases other than allergy, and might be more severely ill than patients with lower sIL-2R levels. sIL-2R may be a good marker for evaluating patients with eosinophilia, as an indicator of the probable etiology and severity of their diseases.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Data Interpretation, Statistical
  • Eosinophilia / blood*
  • Eosinophilia / diagnosis
  • Eosinophilia / etiology
  • Eosinophils / pathology
  • Female
  • Humans
  • Immunoglobulin E / blood
  • Leukocyte Count
  • Lymphocyte Activation
  • Male
  • Middle Aged
  • Receptors, Interleukin-2 / blood*
  • Severity of Illness Index
  • Solubility

Substances

  • Biomarkers
  • Receptors, Interleukin-2
  • Immunoglobulin E